Daniel J. Becker
CIK 1752139 · last filed 2025-05-29
Daniel J. Becker is a corporate insider who has filed 21 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for ZURA, was dated May 29, 2025. Across all open-market trades the lifetime net is +$40.4M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
21
$40.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZURA | Director | — | $3.70 | — | $0 | 1 | 2025-05-29 |
| ACELYRIN, Inc. (SLRN) Delisted | Director | 2,999 | $2.27 | $6.8K | $54.0K | 3 | 2024-07-19 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 5,000 | $21.53 | $107.7K | $80.0K | 3 | 2023-06-26 |
| Pandion Therapeutics, Inc. (PAND) Delisted | Director | 0 | $60.05 | $0 | $16.46M | 4 | 2021-04-01 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | 0 | — | — | $23.81M | 8 | 2020-09-28 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-29 | ZURA | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | — | Disp (D) | −2,999 | $0 | |
| 2024-07-19 | ACELYRIN, Inc. (SLRN) Delisted | Sell (S) | −1 | -$7 | EDGAR |
| 2024-06-11 | ACELYRIN, Inc. (SLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | ACELYRIN, Inc. (SLRN) Delisted | Mixed | +3,000 | $54.0K | EDGAR |
| 2023-05-04 | — | Grant (A) | — | $0 | |
| 2022-06-23 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-01 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +5,000 | $80.0K | EDGAR |
| 2021-04-01 | Pandion Therapeutics, Inc. (PAND) Delisted | Mixed | −2,828,883 | -$169.73M | EDGAR |